Sierra Oncology

$12.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.26 (+2.14%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell SRRA and other stocks, options, and ETFs commission-free!

About SRRA

Sierra Oncology, Inc. Common Stock, also called Sierra Oncology, is a clinical stage drug development company of therapeutics for the treatment of cancer. Read More The firm focuses on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded on May 8, 2003 and is headquartered in Vancouver, Canada. The listed name for SRRA is Sierra Oncology, Inc. Common Stock.

Employees
71
Headquarters
Vancouver, British Columbia
Founded
2003
Market Cap
129.11M
Price-Earnings Ratio
Dividend Yield
Average Volume
67.84K
High Today
$12.40
Low Today
$12.16
Open Price
$12.16
Volume
6.07K
52 Week High
$22.00
52 Week Low
$8.55

Collections

SRRA Earnings

-$3.16
-$2.11
-$1.05
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 2, Pre-Market

You May Also Like